<DOC>
	<DOCNO>NCT02602366</DOCNO>
	<brief_summary>The purpose The Quatro Study assess acceptability , preference , user experience effect sexual behavior four different vaginal microbicide multi-purpose technology ( MPT ) delivery form , use placebo product 18-30 year old African woman : rapidly disintegrate vaginal insert , intravaginal ring ( IVR ) , film gel . The study also examine adherence dosage form objective marker , develop dosage form prior commencement study .</brief_summary>
	<brief_title>The Quatro Study : Acceptability Study ( Placebo ) Vaginal Delivery Forms Preventing HIV Unintended Pregnancy</brief_title>
	<detailed_description />
	<criteria>Age 1830 In good health , determine site Investigator designee base clinical history Willing able comply study procedure attend monthly followup visit Willing able provide inform consent Fluent one languages use study ( English , Shona Zulu ) Not intend travel move research catchment area next 6 month Sexually active define vaginal intercourse male least 4 time per month past 3 month plan sexually active study duration HIV positive Pregnant , intention become pregnant clinical study Prior participation HIVprevention MPT product demonstration study clinical trial Any current historical health ( include vaginal genitourinary condition ) psychological issue site Investigator his/her designee determines exclude potential participant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>DCE</keyword>
	<keyword>MPT</keyword>
	<keyword>Microbicide</keyword>
</DOC>